Literature DB >> 14578870

Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.

David J Woollard1, Arash Grakoui, Naglaa H Shoukry, Krishna K Murthy, Katherine J Campbell, Christopher M Walker.   

Abstract

Resolution of hepatitis C virus (HCV) infection is associated with strong and sustained virus-specific CD4+ T cell responses. In this study, we investigated the evolution of functional T cell responses during acute infection of a chimpanzee and the longevity of these lymphocytes in blood and liver after resolution of infection. Viremia increased through the first 3 weeks of infection and then remained stable until the onset of T cell responses at weeks 6 and 8 postinfection. CD4+ T cells targeting nonstructural HCV proteins were detected in proliferation assays by week 6 postinfection, but they failed to produce interferon gamma (IFN-gamma). HCV-specific CD4+ and CD8+ T cells with the ability to produce IFN-gamma appeared at week 8 when a rapid 10-fold reduction in plasma viremia was first observed. This cytokine response persisted through to week 24 when infection apparently resolved. T cell lines targeting 3 CD4+ T cell epitopes and 1 CD8+ T cell epitope were derived from liver and their Patr major histocompatibility complex (MHC) restriction elements were identified. In retrospective studies performed on cryopreserved peripheral blood mononuclear cells (PBMCs) collected at various timepoints after infection, the onset of an IFN-gamma response measured against the class II restricted epitopes correlated with viral clearance. In conclusion, the characterization of the HCV epitopes and MHC class II restriction elements described here will facilitate a detailed comparison of CD4+ T cell function in animals with resolved and persistent infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578870     DOI: 10.1053/jhep.2003.50478

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Authors:  Harel Dahari; Stephen M Feinstone; Marian E Major
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

2.  Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.

Authors:  J K Flynn; G J Dore; M Hellard; B Yeung; W D Rawlinson; P A White; J M Kaldor; A R Lloyd; R A Ffrench
Journal:  J Viral Hepat       Date:  2010-07-05       Impact factor: 3.728

3.  A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection.

Authors:  Ying Huang; Huiying Yang; Brian B Borg; Xiaowen Su; Shannon L Rhodes; Kai Yang; Xiaomei Tong; George Tang; Charles D Howell; Hugo R Rosen; Chloe L Thio; David L Thomas; Harvey J Alter; Ronda K Sapp; T Jake Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

4.  Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys.

Authors:  Domenico Mavilio; Janet Benjamin; Diana Kim; Gabriella Lombardo; Marybeth Daucher; Audrey Kinter; Elizabeth Nies-Kraske; Emanuela Marcenaro; Alessandro Moretta; Anthony S Fauci
Journal:  Blood       Date:  2005-05-17       Impact factor: 22.113

Review 5.  Advances in alcoholic liver disease.

Authors:  Zhenyuan Song; Swati Joshi-Barve; Shrish Barve; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2004-02

6.  Virus-specific T-cell immunity correlates with control of GB virus B infection in marmosets.

Authors:  David J Woollard; Gholamreza Haqshenas; Xuebin Dong; Bridget F Pratt; Stephen J Kent; Eric J Gowans
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection.

Authors:  David G Bowen; Naglaa H Shoukry; Arash Grakoui; Michael J Fuller; Andrew G Cawthon; Christine Dong; Dana L Hasselschwert; Kathleen M Brasky; Gordon J Freeman; Nilufer P Seth; Kai W Wucherpfennig; Michael Houghton; Christopher M Walker
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

8.  Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.

Authors:  Yinling Lin; Taewoo Kwon; John Polo; Yi-Fei Zhu; Stephen Coates; Kevin Crawford; Christine Dong; Mark Wininger; John Hall; Mark Selby; Doris Coit; Angelica Medina-Selby; Colin McCoin; Philip Ng; Debbie Drane; David Chien; Jang Han; Michael Vajdy; Michael Houghton
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

9.  Kinetic analysis by real-time PCR of hepatitis C virus (HCV)-specific T cells in peripheral blood and liver after challenge with HCV.

Authors:  Ramesh K Ramalingam; Dirk Meyer-Olson; Naglaa H Shoukry; David G Bowen; Christopher M Walker; Spyros A Kalams
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

10.  Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.

Authors:  Michael J Fuller; Naglaa H Shoukry; Toshifumi Gushima; David G Bowen; Benoit Callendret; Katherine J Campbell; Dana L Hasselschwert; Austin L Hughes; Christopher M Walker
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.